Importantly, eIF2α phosphorylation via both PERK and GCN2 enhances the expression of selected proteins, in particular that of ATF4, which enables tumor cell survival and adaptation in c‐Myc‐driven cancer types, including CRC [92, 162]. Here, EIF2A is linked to neoplasm.